The updated analyst work on Aveanna Healthcare Holdings centers on a higher fair value estimate, moving from US$9.95 to US$13.90. This points to a meaningfully higher price target range in the low to mid teens. Analysts tie this shift to the Q2 report, the refreshed long term framework through 2027, and to how reimbursement trends and state rate decisions could influence the stock over time. Read on to see what is driving the evolving story around Aveanna Healthcare Holdings and how you can track the changing analyst narrative.
What Wall Street Has Been Saying
🐂 Bullish Takeaways
-
Several firms, including RBC Capital, Deutsche Bank, Raymond James, BMO Capital and UBS, have raised Aveanna Healthcare Holdings price targets into a US$13 to US$16 range, which aligns with the higher fair value estimates now being discussed.
-
RBC Capital highlights the Q2 performance, higher FY26 guidance and a revised long term growth framework, and points to management commentary on OBBBA positioning that it views as supportive for Private Duty Nursing within Medicaid.
-
BMO Capital cites Q2 revenue and EBITDA ahead of its prior consensus figures along with a constructive reimbursement backdrop across states and Managed Care Organizations, including a California PDN rate change planned for FY27.
-
Truist, UBS and Raymond James reference updated models and outlooks through FY27, with some firms calling out better than expected Q2 earnings and higher long term targets as key inputs to their revised valuation work.
🐻 Bearish Takeaways
-
Truist and UBS maintain Hold or Neutral ratings despite higher price targets. This signals that some analysts still see Aveanna Healthcare Holdings as fairly valued around current ranges and want more proof of consistent execution on the refreshed plan.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!
We've flagged 3 risks for Aveanna Healthcare Holdings. See which could impact your investment.
How This Changes the Fair Value For Aveanna Healthcare Holdings
-
Fair value moves from US$9.95 to US$13.90, which is an increase of about 40% in the updated analysis.
-
Revenue growth assumption rises from about 5.18% to about 7.04% for Aveanna Healthcare Holdings.
-
Net profit margin assumption moves from about 4.48% to about 5.65% on future revenue.
-
Future P/E is broadly stable, shifting from about 23.35x to about 23.78x.
-
Discount rate assumption changes from 7.88% to about 7.54%, reflecting a modest adjustment in the assumed risk profile.
Never Miss an Update: Follow The Narrative
Narratives connect Aveanna Healthcare Holdings' business story to a structured set of assumptions about growth, margins, and risk. They update as new information comes through, so you can see how the investment case is evolving over time.
Head over to the Simply Wall St Community and follow the Narrative on Aveanna Healthcare Holdings to stay up to date on:
-
How demand for in home care, including pediatric and adult services, and an aging population are shaping Aveanna Healthcare Holdings' long term opportunity.
-
The impact of preferred payer agreements, reimbursement changes, and recent acquisitions like Thrive Skilled Pediatric on margins and capacity.
-
Key risks around caregiver recruitment, heavy reliance on Medicaid and Medicare funding, high variable rate debt, and the shift toward more technology enabled home healthcare models.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AVAH .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
